Heska

Heska Corp. engages in the provision of veterinary and animal health diagnostic, and specialty products. It operates through the North America and International segments. The North America segment includes the United States, Canada, and Mexico. The International segment involves Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company was founded by Robert B. Grieve and Lynnor B. Stevenson in 1988 and is headquartered in Loveland, CO.

Earnings data Q1 2024

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Heska Corporation manufactures, develops and sells advanced veterinary diagnostic and specialty healthcare products through its two business segments: North America and International. Both segments include Point of Care Lab testing instruments and consumables, digital imaging products, software and services, data services, allergy testing and immunotherapy, and single-use offerings such as in-clinic diagnostic tests and heartworm preventive products. The North America segment also includes private label vaccine and pharmaceutical production under third-party agreements and channels, primarily for herd animal health.

Heska (HSKA) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Why Earnings Season Could Be Great for Heska (HSKA)

Heska (HSKA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Heska (HSKA) Expected to Beat Earnings Estimates: Should You Buy?

LOVELAND, Colo., Jan. 31, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty products and solutions, will report its fourth quarter and full year 2021 financial performance in a press release before the market opens on Monday, February 28, 2022.

Heska Fourth Quarter and Full Year 2021 Financial Results and Earnings Call Scheduled for February 28, 2022

LOVELAND, Colo., Jan. 3, 2022 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty products and solutions, today announced the completion of the acquisition of VetZ GmbH ("VetZ"), a European trailblazer in veterinary practice information management software solutions ("PIMS") (the "Acquisition").

Heska Corporation Completes Acquisition of VetZ GmbH to Become European Leader in Practice Management Software Solutions

LOVELAND, Colo., Dec. 28, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, announced that Kevin Wilson, Heska's President & Chief Executive Officer, will present at the 40th Annual J.P.

Heska to Present at the Upcoming Annual J.P. Morgan Health Care Conference

Heska Corp Brands, Inc. (HSKA) CEO Kevin Wilson on Q3 2021 Results - Earnings Call Transcript

LOVELAND, Colo., Nov. 4, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or "Company"), a leading provider of advanced veterinary diagnostic and specialty products, reported financial results in two segments (North America and International) for its third quarter ended September 30, 2021.

Heska Corporation Reports Third Quarter 2021 Results

LOVELAND, Colo., Nov. 2, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, announced today that the Company has entered a definitive agreement (the "Agreement") to acquire 100% of VetZ GmbH ("VetZ"), a European leader in veterinary practice information management software solutions ("PIMS") (such transaction, the "Acquisition").

Heska Corporation to Acquire VetZ GmbH, European Leader in Practice Information Management Software Solutions

Alkermes

BioNTech SE

Bruker

Inmode Ltd

Joint

Prothena

It looks like we're on the back end of the Covid pandemic, so it's a good time to look at healthcare stocks that have a big future. The post 7 A-Rated Healthcare Stocks to Buy for the Long Haul appeared first on InvestorPlace.

7 A-Rated Healthcare Stocks to Buy for the Long Haul

Shares of Heska Corp (NASDAQ: HSKA) have lost nearly 20% since late August, but Spruce Point Capital Management says the stock could crash another 60% from here as its current premium valuation is “nonsensical”. Heska's Element AIM will disappoint In its report on Monday, Spruce Point said financial disclosures from Heska were unreliable, citing example […] The post Research opinion: Heska Corp is a ‘strong sell' appeared first on Invezz.

Research opinion: Heska Corp is a ‘strong sell'

LOVELAND, Colo., Oct. 12, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading provider of advanced veterinary diagnostic and specialty products, will report its third quarter 2021 financial performance in a press release before the market opens on Thursday, November 4, 2021.

Heska Third Quarter 2021 Financial Results and Earnings Call Scheduled for November 4, 2021

LOVELAND, Colo., Sept. 9, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, announced today that the Company has acquired majority ownership of Biotech Laboratories U.S.A.

Heska Corporation Acquires Biotech Laboratories to Enter Rapid Assay Point of Care Diagnostics Market

LOVELAND, Colo., Sept. 8, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading provider of advanced veterinary diagnostic and specialty healthcare products, today announced the hire of Anthony Providenti to serve as Executive Vice President, Corporate Development.

Heska Corporation Announces Strategic Hire to Drive Expansion and Execution

Heska Corporation (HSKA) CEO Kevin Wilson on Q2 2021 Results - Earnings Call Transcript

LOVELAND, Colo., Aug. 3, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or "Company"), a leading provider of advanced veterinary diagnostic and specialty products, reported financial results in two segments (North America and International) for its second quarter ended June 30, 2021.

Heska Corporation Reports Second Quarter 2021 Results

LOVELAND, Colo., July 13, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading provider of advanced veterinary diagnostic and specialty products, will report its second quarter 2021 financial performance in a press release before the market opens on Tuesday, August 3, 2021.

Heska Second Quarter 2021 Financial Results and Earnings Call Scheduled for August 3, 2021

AmerisourceBergen

Chewy

Covetrus Inc

Elanco Animal Health Inc

Freshpet

General Mills

IDEXX Laboratories

Merck

Nestle SA

Proshares Pet Care ETF

Patterson Companies

PetIQ

J. M. Smucker

Unicharm Corp

Petco Health and Wellness

Zomedica

Zoetis

The physiological and psychological benefits that pets give us are meaningful. COVID has amplified our appreciation of this. Anticipating 6% annual growth until 2030 may be conservative, even across developed markets.

Overview Of Opportunities In Animal Companionship: A $200B Industry Growing At 6.1% Annually

Not only has Heska stock doubled in a year, it has quintupled over the past five years, and it's a 20-bagger over the last decade. Why is this animal health stock flying so high?

Up 100% in a Year, Can This Animal Health Stock Keep Climbing?

LOVELAND, Colo., May 25, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA - News; "Heska" or the "Company"), a leading global provider of advanced veterinary diagnostic and specialty products, announced that Kevin Wilson, Heska's President and Chief Executive Officer, will present at the following conferences in June 2021: Thursday, June 3, 2021 – Stifel 2021 Virtual Jaws & Paws Conference.

Heska to Present at Upcoming Conferences in June 2021

EverBank Financial

Mesa Laboratories

National Western Life Group

CarParts.com, Inc.

Winmark

These seven small-cap stocks have the potential of rebounding and making it big in the post-pandemic reality of 2021. The post 7 Small-Cap Stocks To Buy for Their Big Ambitions appeared first on InvestorPlace.

7 Small-Cap Stocks To Buy for Their Big Ambitions

Heska's (HSKA) CEO Kevin Wilson on Q1 2021 Results - Earnings Call Transcript

Heska (HSKA) delivered earnings and revenue surprises of 555.56% and 11.48%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

Heska (HSKA) Q1 Earnings and Revenues Top Estimates

LOVELAND, Colo., May 6, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or "Company"), a leading provider of advanced veterinary diagnostic and specialty products, reported financial results in two segments (North America and International) for its first quarter ended March 31, 2021.

Heska Corporation Reports First Quarter 2021 Results

LOVELAND, Colo., April 16, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA) ("Heska" or the "Company"), a leading provider of advanced veterinary diagnostic and specialty products, announces its 2021 Annual Meeting of Stockholders.

Heska Announces its Annual Meeting of Stockholders on May 5, 2021

LOVELAND, Colo., April 8, 2021 /PRNewswire/ -- Heska Corporation (NASDAQ: HSKA; "Heska" or the "Company"), a leading provider of advanced veterinary diagnostic and specialty products, will report its first quarter 2021 financial performance in a press release before the market opens on Thursday, May 6, 2021.

News for Heska Stock (HSKA)